Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new “gray-zone” for the evaluation of “borderline” values
- 30 November 1996
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (5) , 644-648
- https://doi.org/10.1016/s0168-8278(96)80233-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBcJournal of Hepatology, 1993
- Significance of serum IgM anti‐HBc in chronic hepatitis B virus infectionJournal of Medical Virology, 1992
- Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassaysJournal of Medical Virology, 1991
- Serial assay for IGM anti-HBc in patients with anti-HBe-positive chronic hepatitis and its significance for long-term prognosisJournal of Medical Virology, 1988
- Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitisHepatology, 1987
- Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infectionLiver International, 1986
- Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitisGastroenterology, 1985
- Effects of short‐term, high‐dose prednisone treatment of patients with HBsAg‐positive chronic active hepatitisLiver International, 1985
- Detection of Anti-HBc IgM Following Prednisone Treatment in Patients with Chronic Active Hepatitis B Virus InfectionHepatology, 1984
- IgM Antibody to Hepatitis B Core Antigen in Korean Patients with Hepatocellular Carcinoma† ‡Hepatology, 1984